Holen Sie sich die Stockscreener-App
10.26
0.67%
0.0685
Schlusskurs vom Vortag:
$10.19
Offen:
$10.39
24-Stunden-Volumen:
13,045
Relative Volume:
3.43
Marktkapitalisierung:
$702.96M
Einnahmen:
$277.56M
Nettoeinkommen (Verlust:
$-13.33M
KGV:
-54.00
EPS:
-0.19
Netto-Cashflow:
$-6.54M
1W Leistung:
+0.06%
1M Leistung:
-4.95%
6M Leistung:
+12.75%
1J Leistung:
+20.71%
1-Tages-Spanne:
$10.14
$10.46
1-Wochen-Bereich:
$9.7996
$10.46
52-Wochen-Spanne:
$6.65
$12.61
Pharming Group N V Adr Stock (PHAR) Company Profile
Firmenname
Pharming Group N V Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PHAR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHAR
Pharming Group N V Adr
|
10.26 | 697.03M | 277.56M | -13.33M | -6.54M | -0.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Pharming Group N V Adr Stock (PHAR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-09 | Eingeleitet | Jefferies | Buy |
Pharming Group N V Adr Aktie (PHAR) Neueste Nachrichten
Best Momentum Stocks to Buy for July 25th - TradingView
New Strong Buy Stocks for July 25th - TradingView
Best Momentum Stocks to Buy for July 17th - TradingView
New Strong Buy Stocks for July 17th - Yahoo Finance
PHAR stock hits 52-week high at $11.14 amid robust growth By Investing.com - Investing.com South Africa
PHAR stock hits 52-week high at $11.14 amid robust growth - Investing.com India
Pharming To Attend The H.C. Wainwright BioConnect Investor Conference 2023 - Barchart.com
SpringWorks Therapeutics (SWTX) Soars 9.0%: Is Further Upside Left in the Stock? - Nasdaq
META_TITLE_SECTORS - Yahoo Finance
H.C. Wainwright maintains Buy on Pharming with $37 price target - Investing.com
Pharming Group to participate in March investor conference - GlobeNewswire Inc.
Pharming Group N.V. (AMS:PHARM) Held Back By Insufficient Growth Even After Shares Climb 26% - Simply Wall St
Pharming Group stock gains on KL1333’s blockbuster potential, says RBC - Investing.com
Jefferies initiates Pharming Group shares with Buy on revenue growth - Investing.com
Oppenheimer cuts Pharming Group stock target, Outperform on Q3 results - Investing.com
Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last? - Yahoo Finance
RGC Stock Quote Price and Forecast - CNN
symbol__ Stock Quote Price and Forecast - CNN
Why Earnings Season Could Be Great for Pharming Group (PHAR) - Yahoo Finance
Can Pharming Group N.V. Sponsored ADR (PHAR) Run Higher on Rising Earnings Estimates? - Yahoo Finance
Are Medical Stocks Lagging Lantheus (LNTH) This Year? - Nasdaq
PHAR News Today | Why did Pharming Group stock go down today? - MarketBeat
Pharming Group (PHAR) Stock Price, News & Analysis - MarketBeat
Pharming Group (PHAR) - Zacks Investment Research
PHARM Stock Price and Chart — EURONEXT:PHARM - TradingView
Finanzdaten der Pharming Group N V Adr-Aktie (PHAR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):